Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2230
https://www.valueinhealthjournal.com/article/S1098-3015(16)33596-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2114
First Page :
A736
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33596-3&doi=10.1016/j.jval.2016.09.2230